Exicure, Inc. (XCUR) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM), revenue growth -100.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Return on Equity | -847.9% |
| Current Ratio | 0.56 |
| Revenue Growth (YoY) | -100.0% |
| EPS Growth (YoY) | -83.4% |
| FCF Growth (YoY) | 194.0% |
| EV / EBITDA | -0.9 |
| Price / Book | 8.38 |
| FCF Yield | -78.0% |
| Altman Z-Score | -20.22 (distress) |
| Sector P/E (Healthcare) | 21.7 |
XCUR overview · XCUR earnings · XCUR KPIs · XCUR investor relations · XCUR ownership · XCUR peers · XCUR filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.